
- Get in Touch with Us
Last Updated: Apr 25, 2025 | Study Period: 2024-2030
A spirometer is a diagnostic tool that gauges how much air you can inhale and exhale. It keeps track of how long it takes you to finish breathing out after taking a deep breath. You must breathe into a tube connected to a device called a spirometer in order to undergo a spirometry test.
It aids in lung health maintenance or aids in the recovery of weak lungs following an illness or injury. An incentive spirometer can: Improve lung ventilation after surgery. Ventilation is the amount of air that is taken into and expelled from your lungs throughout each breath.
An FEV1/FVC ratio more than 0.70 with both FEV1 and FVC over 80% of the expected value are considered normal spirometry data. TLC exceeding 80% of the predictive value when lung volumes are done is considered normal. A diffusion capacity that is greater than 75% of the projected value is regarded as typical.
A spirometry test calculates how much air is in your lungs by measuring the flow of air through them. Additionally, it reveals to a medical professional how effectively you breathe and how robust your lungs are.
To receive the finest benefits from the workout on your lungs, use a spirometer frequently, just like you would with other exercise equipment. Depending on how frequently you use it each day, you can use it every day.
The Global spirometer market accounted for $XX Billion in 2023 and is anticipated to reach $XX Billion by 2030, registering a CAGR of XX% from 2024 to 2030.
Vyaire Medical Launches Novel Remote AioCare Mobile Spirometer. The AioCare mobile spirometry equipment from HealthUp SA, Poland, has been made available in more than 15 nations around Europe, the Middle East, and Australia, according to a press release from Vyaire Medical.
Asthma and COPD may now be quickly and correctly diagnosed by doctors using this scientifically tested technology, which builds on Vyaire's extensive knowledge in respiratory diagnostics. Additionally, it provides top-notch patient monitoring at home via cutting-edge digital connection.
Through remote monitoring and secure communication, doctors and patients may share and discuss findings using the AioCare system, which comprises a portable spirometer coupled to a special smartphone app and an online panel. Real-time information from specialised algorithms that analyse lung parameters and symptoms help chronic respiratory patients avoid unanticipated effects of illness aggravation.
The SentrySuiteTM software platform from Vyaire will also interface with the AioCare digital health technology, giving medical professionals greater context and knowledge about each patient's particular respiratory status. An estimated 251 million COPD patients and 339 million asthma sufferers go undiagnosed worldwide.
Asthma and COPD place significant financial strains on healthcare systems across the world. Having the correct technologies to help with early detection and continuing treatment is crucial to lowering those expenses. Vyaire will begin selling AioCare in the first 15 countries under the deal with HealthUp SA this month, with further market registrations pending.
Sl no | Topic |
1 | Market Segmentation |
2 | Scope of the report |
3 | Abbreviations |
4 | Research Methodology |
5 | Executive Summary |
6 | Introduction |
7 | Insights from Industry stakeholders |
8 | Cost breakdown of Product by sub-components and average profit margin |
9 | Disruptive innovation in the Industry |
10 | Technology trends in the Industry |
11 | Consumer trends in the industry |
12 | Recent Production Milestones |
13 | Component Manufacturing in US, EU and China |
14 | COVID-19 impact on overall market |
15 | COVID-19 impact on Production of components |
16 | COVID-19 impact on Point of sale |
17 | Market Segmentation, Dynamics and Forecast by Geography, 2024-2030 |
18 | Market Segmentation, Dynamics and Forecast by Product Type, 2024-2030 |
19 | Market Segmentation, Dynamics and Forecast by Application, 2024-2030 |
20 | Market Segmentation, Dynamics and Forecast by End use, 2024-2030 |
21 | Product installation rate by OEM, 2023 |
22 | Incline/Decline in Average B-2-B selling price in past 5 years |
23 | Competition from substitute products |
24 | Gross margin and average profitability of suppliers |
25 | New product development in past 12 months |
26 | M&A in past 12 months |
27 | Growth strategy of leading players |
28 | Market share of vendors, 2023 |
29 | Company Profiles |
30 | Unmet needs and opportunity for new suppliers |
31 | Conclusion |
32 | Appendix |